Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Debt forgiveness | $1,111 | 1 | 88.3% |
| Food and Beverage | $147.00 | 9 | 11.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| KLS-Martin L.P. | $1,111 | 1 | $0 (2021) |
| Janssen Biotech, Inc. | $22.56 | 1 | $0 (2023) |
| ABBVIE INC. | $21.32 | 1 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $19.05 | 1 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $16.85 | 1 | $0 (2023) |
| Greenwich Biosciences, Inc. | $14.23 | 1 | $0 (2021) |
| Relypsa, Inc. | $13.85 | 1 | $0 (2018) |
| PFIZER INC. | $13.23 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $13.10 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $12.81 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40.37 | 2 | ABBVIE INC. ($21.32) |
| 2023 | $52.64 | 3 | Janssen Biotech, Inc. ($22.56) |
| 2021 | $1,138 | 3 | KLS-Martin L.P. ($1,111) |
| 2019 | $12.81 | 1 | Janssen Pharmaceuticals, Inc ($12.81) |
| 2018 | $13.85 | 1 | Relypsa, Inc. ($13.85) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/07/2024 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $19.05 | General |
| 04/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/16/2023 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Rare Disease | ||||||
| 08/01/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Immunology | ||||||
| 04/27/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/27/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/16/2021 | KLS-Martin L.P. | — | Debt forgiveness | Cash or cash equivalent | $1,110.50 | General |
| Category: INSTRUMENTS | ||||||
| 08/04/2021 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Neurology | ||||||
| 05/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/01/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 473 | 647 | $327,290 | $81,485 |
| 2022 | 11 | 363 | 466 | $161,051 | $56,207 |
| 2021 | 14 | 430 | 585 | $245,510 | $86,330 |
| 2020 | 18 | 520 | 753 | $293,707 | $98,897 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 63047 | Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | Facility | 2023 | 30 | 30 | $87,510 | $21,188 | 24.2% |
| 22551 | Fusion of upper spine bone with removal of disc and release of spinal cord or nerve, 1 disc | Facility | 2023 | 11 | 11 | $48,939 | $12,507 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 92 | $33,396 | $7,529 | 22.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 62 | 179 | $19,332 | $6,399 | 33.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $24,440 | $5,794 | 23.7% |
| 63048 | Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment | Facility | 2023 | 19 | 31 | $16,926 | $4,394 | 26.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 36 | $20,052 | $4,377 | 21.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 45 | $17,010 | $4,303 | 25.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $17,416 | $4,224 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 31 | $15,841 | $4,087 | 25.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 57 | $11,400 | $3,228 | 28.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 21 | 22 | $6,116 | $1,328 | 21.7% |
| 20931 | Graft of donor bone to spine | Facility | 2023 | 16 | 16 | $4,560 | $1,160 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 17 | $4,352 | $965.60 | 22.2% |
| 63047 | Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | Facility | 2022 | 25 | 25 | $56,175 | $18,356 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 125 | $29,000 | $11,499 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $25,826 | $8,731 | 33.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 80 | $12,560 | $4,298 | 34.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 36 | $10,584 | $3,566 | 33.7% |
| 63048 | Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment | Facility | 2022 | 15 | 21 | $9,051 | $3,073 | 33.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 14 | $4,354 | $1,781 | 40.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $4,840 | $1,757 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 23 | $3,634 | $1,509 | 41.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 29 | 45 | $3,825 | $1,297 | 33.9% |
| 72050 | X-ray of upper spine, 4-5 views | Office | 2022 | 11 | 12 | $1,202 | $339.67 | 28.3% |
About Dr. Chinyere Obasi, MD
Dr. Chinyere Obasi, MD is a Neurological Surgery healthcare provider based in Kearney, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245313253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chinyere Obasi, MD has received a total of $1,258 in payments from pharmaceutical and medical device companies, with $40.37 received in 2024. These payments were reported across 10 transactions from 10 companies. The most common payment nature is "Debt forgiveness" ($1,111).
As a Medicare-enrolled provider, Obasi has provided services to 1,786 Medicare beneficiaries, totaling 2,451 services with total Medicare billing of $322,918. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Neurological Surgery
- Other Specialties Neurological Surgery
- Location Kearney, NE
- Active Since 10/23/2006
- Last Updated 02/20/2017
- Taxonomy Code 207T00000X
- Entity Type Individual
- NPI Number 1245313253
Products in Payments
- REMICADE (Biological) $22.56
- BOTOX (Biological) $21.32
- ULTOMIRIS (Biological) $16.85
- Epidiolex (Drug) $14.23
- Veltassa (Drug) $13.85
- ELIQUIS (Drug) $13.23
- DIFICID (Drug) $13.10
- XARELTO (Drug) $12.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.